Chantibody Therapeutics
HOME
OUR COMPANY
  • ABOUT US
  • OUR PLATFORM
  • PUBLICATIONS
CAREER
CONTACT US
Chantibody Therapeutics
HOME
OUR COMPANY
  • ABOUT US
  • OUR PLATFORM
  • PUBLICATIONS
CAREER
CONTACT US
More
  • HOME
  • OUR COMPANY
    • ABOUT US
    • OUR PLATFORM
    • PUBLICATIONS
  • CAREER
  • CONTACT US
  • HOME
  • OUR COMPANY
    • ABOUT US
    • OUR PLATFORM
    • PUBLICATIONS
  • CAREER
  • CONTACT US

AACR Chicago, 2025

CT111 Trispecific antibodyCT224 T-cell engangerCARP New Discovery PlatformJL-Lightning CAR-TMSLN + MUC1 dual targeting CAR-T

Papers

Distinct types of VHHs in Alpaca (pdf)

Download

Antitumor activity of Z15-0-2 (pdf)

Download

Past Event Posters

SITC 2024 - Rational design of pH-dependent MSLN-targeting VHHs for CAR-T therapy (pdf)Download
AET 2024 - Distinct types of VHHs in Alpaca (pdf)Download
AET 2022 - A Novel ML+NGS empowered VHH discovery platform and its application in CAR-T therapies (pdf)Download

Copyright © 2025 Chantibody Therapeutics - All Rights Reserved.

Powered by